Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Phase II Study of Recombinant Vaccinia-NY-ESO-1 (rF-NY-ESO-1) and Recombinant Fowlpox-NY-ESO-1 (rF-NY-ESO-1) in Patients With Epithelial Ovarian, Fallopian Tube or Primary
Brief Summary:
RATIONALE: Vaccines made from a gene-modified virus may help the body build an effective immune response to kill tumor cells.
PURPOSE: This phase II trial is studying how well vaccine therapy works in treating patients with stage II, stage III, or stage IV ovarian epithelial, fallopian tube, or peritoneal cancer.